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Neuralstemandprogenitorcellsarelocatedinthesubependymaoftheadultforebrain.Anincreaseinadultsubependymalcellprolif-
eration is reported after various kinds of brain injury. We demonstrate an expansion of neural precursor cells in the postnatal sub-
ependymainamurinegeneticdiseasemodelofHuntington’sdisease(HD),theR6/2mouse.Weusedtheinvitroneurosphereassayasan
index of the number of neural stem cells in vivo and to assess proliferation kinetics in vitro and in vivo bromodeoxyuridine labeling to
assesstheprogenitorcellpopulationandtheirfates.Diseaseprogressioninthismodelleadstoanincreaseinthenumbersofneuralstem
cellsintheadultstriatalsubependyma.Thisincreaseisproducedcellnon-autonomouslybyeventsintheR6/2brainsasthemicebecome
increasinglysymptomatic.Oncetheneuralstemcellincreaseisinducedinvivo,itismaintainedduringinvitropassagingofneuralstem
cells,buttheneuralstemcellincreaseisnotreproducedduringinvitropassagingofneuralstemcellsfrompresymptomaticR6/2mice.
In addition, we show that some of the R6/2 neural progenitor cells show a change from their normal migration destiny toward the
olfactorybulb.Instead,someofthesecellsmigrateintothestriatum,oneofthemainaffectedareasinHD.Ourfindingsdemonstratethat
HDdamagerecruitsprecursorcellsintwoways:expansionofneuralstemcellsandalteredmigrationofprogenitorcells.
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Introduction
Stem cells (long-term self-renewing, multipotent precursors)
and progenitor cells (renewal- and lineage-restricted precursors)
reside in the adult ventricular subependyma and generate new
neurons and glia in vivo (Weiss et al., 1996; Seaberg and van der
Kooy, 2003). A major neurogenic system in the adult forebrain
lies in the lateral ventricle subependyma, in which neural stem
cells give rise to neuroblasts that migrate long distances to the
olfactory bulb and differentiate into interneurons (Lois and
Alvarez-Buylla, 1994). Increased proliferation in adult forebrain
subependyma occurs in various brain injury models, including
aspiration or transection lesions, inflammatory or chemical de-
myelination, and percussion trauma (Holmin et al., 1997; Calza
et al., 1998; Jin et al., 2001; Parent et al., 2002). Moreover, stroke
induces adult subependymal cells to proliferate and migrate in
chain-like formations into the damaged striatum (Arvidsson et
al.,2002).Wesoughttodeterminewhetherpostnatalsubependy-
mal precursor cells undergo recruitment in a genetic disease
modelthatcausesforebraindeficitsand,ifso,thenwhichtype(s)
of neural precursor cell (neural stem or neural progenitor cells)
are primarily affected.
Huntington’s disease (HD) is an inherited human neurode-
generative disorder resulting in neuronal cell death in discrete
brain regions attributable to an expanded CAG repeat in the
huntingtin gene (The Huntington’s Disease Collaborative Re-
search Group, 1993). The brain structures primarily affected in
HD are the striatum and the cerebral cortex (for review, see
Sathasivametal.,1999).Becauseoftheintimateproximityofthe
striatum to the adult subependyma, HD may potentially provide
an optimal condition to investigate the ability of endogenous
subependymal precursor cells to regenerate damaged cells in the
adult CNS. The HD R6/2 mouse is a transgenic model of Hun-
tington’sdiseaseinwhichthereiscellularexpressionofexon1of
the mutant (expanded CAG repeats) huntingtin gene. These
transgenicmiceappeartodevelopnormallyintheearlypostnatal
period but display subtle deficits at 5–6 weeks of age, which
progress to motor impairments analogous to those observed in
HD by 9–12 weeks of age, with death occurring between 16 and
18 weeks (Mangiarini et al., 1996; Carter et al., 1999). An in-
creased number of proliferating adult subependymal cells and
new neurons are seen in the HD human brain, especially in pa-
tients with advanced HD (Curtis et al., 2003, 2005a,b). In con-
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seen in R6/2 mice, and, instead, an age-related decline in hip-
pocampalneurogenesisisobservedinthismodelcomparedwith
wild-type (WT) littermates (Gil et al., 2004; Phillips et al., 2005).
We now report that symptomatic HD R6/2 mice have an in-
creased number of neural stem cells (NSCs) in the striatal sub-
ependyma as measured by the clonal neurosphere assay in vitro,
along with in vivo immunohistochemical and electron micro-
scopicanalyses.Moreover,thisincreasednumberofNSCsispro-
duced cell non-autonomously by events in the R6/2 brains as the
mice become progressively symptomatic. Additionally, R6/2
neural progenitor cells display disrupted migration in vivo, and
some are redirected away from the olfactory bulb into the dam-
aged striatum.
MaterialsandMethods
Subjects. All mice were derived from heterozygous breeding of R6/2
/
miceandtheirwild-typecontrolstrain(B6CBAF1/J),kindlyprovidedby
the laboratories of Dr. Anne Messer (Wadsworth Center at the David
Axelrod Institute, Albany, NY) and Dr. Harold Robertson (Dalhousie
University, Halifax, Nova Scotia, Canada). R6/2 mice possess an ex-
panded exon 1 CAG repeat of the human HD gene (140–147) under
control of the human IT15 promoter and recapitulate many of the fea-
tures of human HD (Mangiarini et al., 1996; Carter et al., 1999; Lione et
al., 1999).
Neurosphere assay. We used the in vitro neurosphere assay (Reynolds
and Weiss, 1992; Morshead et al., 1994) to index the number of neural
stem cells in vivo. Subsequently, the self-renewal and expansion charac-
teristicsoftheneuralstemcellsinvitroweredeterminedbyserialpassag-
ing of neurospheres. The differentiation characteristics of neural stem
cell progeny in vitro were determined by plating neurospheres in the
presence of serum (Tropepe et al., 1999).
The subependyma of the lateral ventricle was dissected as described
previously(Morsheadetal.,1998).Subependymaltissuewassubjectedto
enzymaticdigestion(1.33mg/mltrypsin,0.67mg/mlhyaluronidase,and
0.2mg/mlkynurenicacid)for50minat37°Candthenisolatedinserum-
free media (SFM) with trypsin inhibitor. Tissue from all ages was me-
chanically dissociated into a single-cell suspension with a small-bore,
fire-polished Pasteur pipette. Cell density and viability were determined
using trypan blue exclusion.
Cells were cultured in the neurosphere assay under clonal conditions.
Cells were plated at 10 cells/l in 24-well (0.5 ml/well) uncoated plates
(Nunclon; Nunc, Naperville, IL) in serum-free medium containing 20
ng/ml epidermal growth factor (mouse submaxillary; Sigma, St. Louis,
MO),10ng/mlfibroblastgrowthfactor-2(humanrecombinant,Sigma),
and 2 g/ml heparin (Upstate Biotechnology, Lake Placid, NY). Under
these conditions, neurosphere colonies are derived from single cells and
serveasanindexofthenumberofinvivoneuralstemcells(Morsheadet
al., 2003). The total number of spheres that formed in each well was
counted after 7 d.
To determine the self-renewal capacity, we mechanically dissociated
spheres into single-cell suspensions either individually or in bulk and
recultured them under the same conditions as primary cultures, and the
number of neurospheres was determined after 7 d. This was repeated at
weekly intervals, and previous reports demonstrated that the neuro-
spheres passaged up to 10 times (i.e., 10 weeks in vitro) are virtually
identicaltoprimarycultures(ReynoldsandWeiss,1996;Morsheadetal.,
2002).
To determine neuronal and glia differentiation of neural stem cell
progeny in vitro, single spheres were differentiated in 24-well plates
coated with Matrigel basement membrane matrix (0.6 mg/ml in SFM;
Becton Dickinson, Mountain View, CA) containing 0.5 ml of SFM con-
taining 1% fetal bovine serum (Invitrogen, Carlsbad, CA). Wells were
processed 7 d later using immunocytochemistry as described previously
(Tropepe et al., 1999).
Bromodeoxyuridinelabeling,immunocytochemistry,andquantification.
To index the total population of constitutively proliferating cells in the
subependyma, mice were injected with bromodeoxyuridine (BrdU) (60
mg/kg, i.p., in saline; Sigma) every 3 h for a total of five injections and
were killed 1 h after the final injection. To investigate the migration of
BrdU-labeled neuroblasts along the rostral migratory stream into the
olfactory bulb, animals were injected with BrdU and killed 7 d later. To
examine the migration of BrdU-labeled neuroblasts into the striatum
and the cerebral cortex, animals were injected with BrdU and killed 30 d
later. In all cases, animals were overdosed with pentobarbital and per-
fused transcardially with PBS and 4% paraformaldehyde. Brains were
removed and postfixed overnight, cryoprotected with 30% sucrose in
PBSat4°C,andthensectionedat14mthicknessonacryostat.Sections
were incubated in 1N HCl at 60°C for 30 min, then rinsed in PBS, and
subsequentlyincubatedinratanti-BrdUantibody(1:100;Seralab,Craw-
ley, UK) at 4°C overnight, followed by FITC donkey anti-rat antibody
(1:200; Jackson ImmunoResearch, West Grove, PA) for 2 h. The total
number of BrdU-labeled cells in the subependyma was estimated using
the optical dissector method (Coggeshall and Lekan, 1996) in sections
randomlyselectedwithinthemidportionoftheanteriorlateralventricle.
Numbers of BrdU-labeled cells in the granule cell layer (GCL) of the
main olfactory bulb were determined in randomly selected sections ex-
tending1mmanteriortotherostralportionoftheaccessoryolfactory.
We also quantified numbers of labeled cells expressing endogenous
markers of proliferating cells using the mouse monoclonal anti-
proliferating cellular nucleus antigen (PCNA) (1:200; Oncogene, Cam-
bridge, MA) and migrating neuroblasts using the monoclonal anti-
polysialylated neural cell adhesion molecule (PSA-NCAM) (1:200;
Chemicon, Temecula, CA), both visualized with Alexa Fluor 555 goat
anti-mouse (1:400; Invitrogen). For double staining of BrdU and nestin,
GFAP or neuronal-specific nuclear protein (NeuN), anti-nestin mono-
clonal (Chemicon), anti-GFAP monoclonal (DakoCytomation, High
Wycombe, UK), and anti-NeuN monoclonal (Chemicon) were used in
dilutions of 1:100, 1:1000, and 1:200, respectively. Alexa Fluor 568 sec-
ondaryantibodies(Invitrogen)wereusedinadilutionof1:300.Fluores-
cence was visualized using a Nikon (Tokyo, Japan) Microphot micro-
scope or a Zeiss (Oberkochen, Germany) Apotome microscope.
BrdU labeling of neurosphere cultures was used to estimate the cell
cycle time of neural progenitor cells, which make up the vast majority of
cells in the neurospheres (Weiss et al., 1996). As described previously
(Kippin et al., 2005a), neurospheres were prepared as above with the
addition of BrdU (1 M) during the last 1, 6, or 12 h of culturing (i.e., all
cellsharvestedatthesametime,7dafterthestartoftheculture).Afterthe
prescribed BrdU exposure, neurospheres were collected in bulk, dissoci-
ated into single cells, plated onto Matrigel-coated plates in SFM without
growth factors for 1 h, fixed with 4% paraformaldehyde for 20 min, and
washed with PBS. Cells were stained using the same procedure as above
and counterlabeled with Hoechst dye. The proportion of BrdU-labeled
nuclei was determined for neurosphere cultures derived from separate
animals in WT and HD groups.
Electron microscopy. R6/2 and WT mice (n  3) were overdosed with
pentobarbital and perfused transcardially with 0.9% saline, followed by
2% paraformaldehyde and 2.5% glutaraldehyde, for conventional elec-
tron microscopy (EM). The heads were removed and postfixed in the
same fixative overnight. Then the brains were removed from the skull
andwashedin0.1 Mphosphatebufferfor2h.Sagittal4mmsectionswere
cutwitharazorblade.Thesectionswerepostfixedin2%osmiumfor2h,
rinsed, dehydrated, and embedded in Epon (Electron Microscopy Sci-
ences, Fort Washington, PA). For the identification of individual cell
types, transverse ultrathin (0.05 mm) sections of the wall of the lateral
ventricle were cut with a diamond knife, stained with lead citrate, and
examined under a Jeol (Peabody, MA) 100CX electron microscope. The
transverse ultrathin sections studied encompassed the entire anterior
horn extent of the subependymal zone of the lateral ventricle. The clas-
sification of cell types was done as described previously (Doetsch et al.,
1997).
Cellcounts.Theproportionofthedifferentcelltypesinthesubependy-
malzoneofthewallofthelateralventriclewasestimatedbycountingthe
number of profiles corresponding to the different cell types along the
dorsoventral extent of the subependymal zone at the electron micro-
scope.Thisanalysiswasdoneonlyattheanteriorhornlevelofthelateral
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the wall of the lateral ventricle and the number of profiles exposed in
ultrathin electron microscopic sections is a fair representation of the
composition of the subependymal zone (Doetsch et al., 1997).
Statistical analyses. Factorial design ANOVA, t tests, or Mann–Whit-
ney U test were used to analyze data as appropriate (see below). Signifi-
cantANOVAvalueswerefollowedbyposthoccomparisonsofindividual
means using the Tukey’s method. The level of significance for all com-
parisons was 0.05.
Results
Striatalsubependymalneuralstemcellsincrease
progressivelywiththeageofR6/2 animals
The in vitro neurosphere assay (Reynolds and Weiss, 1992; Mor-
shead et al., 1994) was used to characterize the forebrain sub-
ependymal neural stem cell population of the R6/2 mouse, with
the numbers of clonal neurospheres in vitro serving as a measure
ofthenumbersofneuralstemcellsinvivo(Morsheadetal.,1994,
1998). Relative to WT mice, the numbers of forebrain sub-
ependymal neurospheres initially are unchanged in asymptom-
atic R6/2 mice (at 4.5 weeks of age) (Fig. 1A). However, there is
an interaction of age and strain at 8 and 12 weeks of age, when
significantly more neurospheres can be derived from the R6/2
forebrainsubependymarelativetoWT(F(5,42)3.44;p0.05).
At 8 weeks of age, when R6/2 mice display behavioral deficits,
such as irregular gait, stereotypic grooming movements, tremor,
clasping, and tonic–clonic seizures (Sathasivam et al., 1999),
there is an increase in the proportion of subependymal cells that
formneurospheresrelativetoWT.At12weeksofage,whenR6/2
mice are approaching the terminal point of this HD model, the
proportion of subependymal cells that form neurospheres is in-
creased threefold relative to WT. This increase in proportion of
cells forming neurospheres may reflect either an increase in the
absolute number of stem cells or a decrease in the proportion of
non-stemcellsintheregiondissected(i.e.,thenumberofneuro-
spheres per well could go up without the stem cell population
expanding if other cell types are decreasing). We therefore ex-
pressed the data as the total numbers of neurospheres per fore-
brain (Fig. 1B), which confirmed that R6/2 mice exhibit a pro-
gressive increase in the absolute numbers of neural stem cells in
the striatal subependyma with significantly more neural stem
cells at 8 and 12 weeks (but not 4.5 weeks) of age relative to
age-matched WT controls (F(5,83)  43.96; p  0.05).
Long-term (30 d) retention of BrdU labeling of NSCs in the
subependyma in vivo confirmed the increase in NSC numbers in
symptomaticR6/2mice.Long-termretentionofBrdUquantifies
theproliferatingportionoftherelativelyquiescentNSCsbutnot
the rapidly dividing progenitors cells, which migrate out of the
subependyma, undergo cell death, or dilute out the marker
within 30 d (Morshead and van der Kooy, 1992; Luskin, 1993;
Lois and Alvarez-Buylla, 1994; Morshead et al., 1998; Hitoshi et
al.,2002).R6/2andWTmicereceivedaseriesoffiveBrdUinjec-
tions over 12 h at 8 weeks of age and were killed 30 d later (at 12
weeksofage).R6/2miceshowedincreasednumbersofcellsinthe
subependyma of the lateral ventricle that retained the BrdU label
for 30 d relative to WT (t(38)  3.11, p  0.05; 4591  217
BrdU-labeled cells/mm
3 for the WT mice; for the R6/2 mice,
8393  138). These BrdU-positive (BrdU
) cells were later ana-
lyzed using specific markers. Figure 2 shows the percentage of
BrdU
 cells of different phenotypes in the subependyma, after
30 d of BrdU retention. Immunostaining showed that the per-
centages of BrdU
 cells also positive for NeuN, nestin, or GFAP
are the same in WT and R6/2 mice (i.e., the relative cell fates do
not change in the HD model). Given that 80% of the cells are
GFAP
 and 80% of the cells are nestin
, most cells must ex-
press both markers and thus are very likely to be stem cells. All
double labeling of cells was confirmed with confocal microscope
analyses.Thetotalnumberofstainedcellsis100%,butitisvery
unlikelythatcellsarestainingforbothneuronal(NeuN)andglial
(GFAP)markers.Thus,wemayhaveoverestimatedthenumbers
ofGFAPandnestincytoplasmicstainingcells,becauseevenwith
Figure1. SubependymalstemcellsincreaseprogressivelywiththeageofR6/2micecom-
pared with WT. A, Number of neurospheres per 5000 plated cells derived from the forebrain
(lateralventriclesubependyma)fromWTandR6/2miceat4.5,8,and12weeksofage.B,Total
numberofneurospheresperforebrain(fromthelateralventriclesubependyma)derivedineach
condition.AlldataareexpressedasmeanSEM.*p0.05.
Figure 2. Phenotypes of BrdU-positive cells in the subependyma of WT and R6/2 mice.
SpecificmarkerswereusedtocharacterizeBrdU
cells30dafterBrdUinjection.Therewereno
significantdifferencesbetweenthepercentagesofBrdU
cellsdoublelabeledforNeuN(t(3)
0.109;p0.05),nestin(t(4)0.0707;p0.05),orGFAP(t(4)0.186;p0.05)between
WTandR6/2mice.However,mostoftheBrdU-labeledcellswerealsonestin
andGFAP
,the
typicalneuralstemcellphenotype.
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cytoplasmic staining marks the same cell as the nuclear BrdU
staining.
EM-definedBcellsareincreasedintheR6/2 subependyma
To better characterize the cells in the R6/2 subependyma com-
pared with WT, subependymal tissue was processed for EM. The
morphology of A cells (Fig. 3A) were identified by an elongated
cellbodywithoneortwoprocesses,abundantlaxchromatinwith
two to four small nucleoli, and dark cytoplasm (Doetsch et al.,
1997).TypeBcells(Fig.3B)hadirregularcontoursthatprofusely
filled the spaces between neighboring cells. These cells had irreg-
ularnucleithatfrequentlycontainedinvaginations(Fig.3C).The
cytoplasm of type B cells was light. Salient characteristics of type
Bcellswerealsotheirdensebodiesinthecytoplasm.SometypeB
cells were common adjacent to ependymal cells, in which they
extended many processes to form a lamina covering the ependy-
mal layer. In some cases, these type B cells were localized most
frequently at the interface with the striatal parenchyma. Type C
cells(Fig.3C,F)differedfrombothtypeAcells(putativemigrat-
ing cells) and type B cells (astrocytes). Type C cells were larger,
more spherical (less elongated), and more electron-lucent than
type A cells but more electron-dense than type B cells.
WT subependyma comprised five to six layers of cells
(Doetsch et al., 1997). R6/2 brains, in contrast, appeared to have
an expanded subependymal width. Another distinct feature was
the location of some of the migratory A cells along with B and C
cells farther from the lumen of the lateral ventricle in the R6/2
(150–200mawayfromependymalcells)comparedwithWT
mice. The ratio of type A/B/C cells in WT subependyma was
2.6:2:1 (Fig. 3G), very close to the previously described ratio of
3:2:1 (Doetsch et al., 1997). Conversely, the ratio type of A/B/C
cells in R6/2 subependyma was 3:4:1, showing that B cells are at
least twofold increased in HD mouse model, whereas A and C
cells showed only small changes in these ratios comparing WT
and R6/2 mice.
R6/2neuralstemcellsmaintaingreaterself-renewalduring
passaging in vitro compared with WT
To investigate self-renewal characteristics of R6/2 striatal sub-
ependymal neural stem cells, primary spheres were individually
dissociated into single cells and replated in identical media con-
ditions.Throughtheuseofthispassagingassay,self-renewalabil-
ity is assessed by the formation of clonally derived secondary
spherecolonies.Thenumberofspheresthatformateachpassage
isameasureofthenumberoftimestheprimarysphere-initiating
cellhassymmetricallydividedinvitro(ReynoldsandWeiss,1996;
Hitoshietal.,2002).Whenweperformedsingle-spherepassaging
of primary spheres derived from R6/2 and WT mice at 12 weeks
of age, we found that R6/2 subependymal stem cells display
greater expansionary self-renewal compared with WT spheres
(t(47)2.36,p0.05;6.308.51secondaryspheresperprimary
colony for the WT mice; 33.98  19.10 for the R6/2 mice). WT
and R6/2 primary spheres were not significantly different in di-
ameter, suggesting that the primary sphere progenitor cells did
not differ between WT and R6/2.
The self-renewal capacity of neural stem cells also was ana-
lyzed through bulk passaging of neurosphere cultures (Fig. 4A).
R6/2 and WT neurospheres were mechanically dissociated into
single-cell suspension in bulk and recultured under the same
conditionsasprimarycultures,andthenumbersofneurospheres
were counted after 7 d. Bulk passaging (Fig. 4A) also revealed
increased stem cell symmetric divisions in cultures from R6/2
mice at 12 weeks of age relative to WT during serial passaging
(F(5,203)  54.26; p  0.05), with increased numbers of neuro-
spheres in both secondary and tertiary R6/2 cultures relative to
WT. These findings demonstrate that the increase in symmetric
divisions once induced is intrinsically maintained by R6/2 stem
cells across multiple passaging in vitro, suggesting that the in-
crease in stem cells observed in vivo (Fig. 1A,B) is attributable to
some factor reprogramming stem cells to undergo symmetric
divisions during HD progression.
Theincreaseinself-renewalisinducedcellnon-
autonomouslyinR6/2forebrainstem cells
Given that, once the age-dependent increase in R6/2 stem cell
symmetric division is induced and it can be maintained in vitro,
we hypothesized that, if the enhancement of self-renewal in R6/2
Figure3. ElectronmicroscopyanalysisshowaspecificincreasenumberofBcells(b)inthe
subependymaoftheanteriorhornofthelateralventricleoftheR6/2mice.A,B,Typicalependy-
malandsubependymalcellsfromtheWTanteriorhornofthelateralventricle.A(a)andBcells
are seen among cell processes. C–F, Subependymal cells from the same region in R6/2 mice
showingA,B,andC(c)celltypes.ThissubependymaisthickercomparedwiththeWToneinC.
In D, a representative area with predominant B cells. In E, note the unusual location of the
migratoryAcellswithBandCcellsawayfromthelumenofthelateralventricle,withintheR6/2
striatalfibers(f).F,BandCcellswerealsofartherawayfromthelumenoftheventriclethanin
WTmice,amongcellprocesses.GshowstheratiooftypeA/B/Ccellsinthesubependymaofthe
anteriorhornofthelateralventricleinWTandR6/2mice.e,Ependymalcells.Scalebar:A,B,1.8
m;C,E,F,1.6m.
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to reproduce this effect during serial passaging of R6/2 stem cells
derived from presymptomatic mice. As indicated in Figure 1, A
andB,asymptomaticR6/2mice(at4.5weeksofage)havesimilar
numbers of neurosphere-forming cells as WT mice in vivo. After
serial bulk passaging of neurosphere cultures derived from mice
at 4.5 weeks of age for a period of 6 weeks (comparable with
primary neurospheres derived from mice at 10.5 weeks of age),
the numbers of clonal neurospheres remained similar in R6/2
and WT cultures (Fig. 4B)( F(13,115)  1.83; p  0.05). Thus, the
production of more clonal primary neurospheres seen at the
symptomatic older ages (e.g., 8 weeks and beyond) in R6/2 com-
pared with WT mice (Figs. 1A,B,4 A) is not acquired during
passaging in vitro over a similar time period during which an
increase in neural stem cells is seen in vivo in the R6/2 forebrain.
Together, these findings suggest two conclusions. First, the in-
crease in neural stem cell numbers and self-renewal is induced
cell non-autonomously by the in vivo R6/2 host brain. Second,
onceinducedinvivo,thispotentiatedself-renewaleffectismain-
tained cell autonomously in vitro.
To determine multipotentiality of R6/2 and WT primary
clonal neurospheres, single spheres (from 12 weeks of age mice)
were differentiated in 24-well plates coated with Matrigel base-
ment membrane matrix containing the standard media plus 1%
fetal bovine serum. Wells were processed 7 d later using immu-
nocytochemistry for III-tubulin (neurons), GFAP (astrocytes),
orO4(oligodendrocytes).R6/2andWTspheresgeneratedequiv-
alent proportions of neurons (6.3  1.6 and 5.7  1.2, respec-
tively),astrocytes(90.311.7and91.210.4,respectively),and
oligodendrocytes(2.90.8and3.10.7,respectively)(F1.0;
p  0.05). Thus, the potentiated self-renewal of forebrain stem
cellsassociatedwithonsetofHDsymptomsisnotassociatedwith
changes in multipotentiality in R6/2 mice.
Theincreaseinforebrainneuralstemcellsdoesnotaffect
neuralprogenitorcellsintheadultforebrainstriatal
subependyma in R6/2 mice in vitro or in vivo
Next,weexaminedtheeffectofmutanthuntingtinontheconsti-
tutively proliferating progenitor cells in the subependyma of
symptomatic R6/2 mice. Because these progenitor cells make up
the vast majority of cells in the neurospheres (Reynolds and
Weiss, 1996), we determined their proliferation kinetics using
incorporation of BrdU in R6/2 and WT neurosphere cultures.
CumulativeBrdUlabelingofprimaryneurosphereculturesfrom
the subependyma of WT and R6/2 mice at 12 weeks of age re-
vealed no significant difference in the proliferation of R6/2 and
WT progenitor cells in vitro (Fig. 5A). There was a significant
effect of time of BrdU exposure (F(5,56)  8.47; p  0.05), with
higher numbers of BrdU-labeled cells after 12 h of exposure (for
Figure4. ForebrainstemcellsfromsymptomaticR6/2micedisplayenhancedself-renewal
induced cell non-autonomously in the R6/2 brain, but, once induced, this enhanced self-
renewalismaintainedinvitro.A,Serialbulkpassagingofneurospherecoloniesfromsymptom-
atic,12-week-oldR6/2andWTmiceforebrains.Bulkpassageswereperformedevery7d.B,
BulkpassagesofneurospherecoloniesfrompresymptomaticR6/2andWTmice(at4.5weeksof
age) over 6 weeks yields equivalent numbers of neural stem cells. All data are expressed as
meanSEM.*p0.05.
Figure5. Theincreaseinforebrainneuralstemcellsdoesnotaffectprogenitorcellsinthe
adult forebrain subependyma in R6/2 mice. A, Cumulative BrdU labeling of primary neuro-
sphereculturesfromWTandR6/2micesubependymaat12weeksofage.Neurospherecultures
fromR6/2donotincorporateBrdUfasterthanneurospheresfromWTlittermatesinvitro.B,C,
Photomicrographs of neural progenitor cells from symptomatic R6/2 (12 weeks of age) and
theirWTlittermateforebraincontrolsinvivoimmunolabeledwithPCNAandBrdUonthesame
slidesectionstoconfirmthesamelevelsoflabelingforbothmarkers.D,Therewasnodifference
inthetotalnumbersofPCNA-orBrdU-labeledcellsbetweenR6/2andWTlittermatecontrols.
AlldataareexpressedasmeanSEM.Scalebar:B,C,80m.
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exposure) but no significant interaction between genotype and
time of exposure or effect of genotype.
To estimate the entire constitutively proliferating progenitor
cell population in the adult R6/2 forebrain striatal subependyma
invivo,weinjectedBrdUevery3hfor15htocovertheentirecell
cycle time of the constitutively proliferating progenitor cells
(MorsheadandvanderKooy,1992;Morsheadetal.,1994,1998).
We found no difference in the total numbers of BrdU-labeled
cells in the subependyma between symptomatic R6/2 (12 weeks
of age) and their WT littermate controls in vivo (Fig. 5B–D).
Similarly, immunostaining against PCNA revealed similar num-
bers of labeled cells in the subependyma of R6/2 and WT brains
(F(3,32)0.278;p0.05).Additionally,quantificationofBrdU-
labeled cells in the subependyma 1 h after a single injection of
BrdU also failed to detect differences between symptomatic R6/2
and WT progenitor cell populations. These data suggest that
there is no effect on progenitor cell population in the R6/2 adult
forebrain subependyma in vivo.
R6/2progenitorshaveadeficitinmigrationtotheolfactory
bulbandareredirectedtothe striatum
To ask whether the expanded neural stem cell population in the
R6/2 mouse subependyma has consequences for one of the pri-
mary fates of these cells (the production of new adult olfactory
bulb interneurons), mice at 12 weeks of age were injected with
BrdU and killed 7 d later, when many of the BrdU-positive cells
areexpectedtobeintheGCLofthemainolfactorybulb(Loisand
Alvarez-Buylla, 1994; Craig et al., 1999). We observed signifi-
cantly lower densities of BrdU-positive cells in the GCL of the
R6/2 mice relative to WT (t(4)  3.43, p  0.05; 12,638  3520
BrdU-labeled cells/mm
3 for the WT mice; for the R6/2 mice,
3193  689) (Fig. 6A,B).
Given this neurogenesis deficiency in the R6/2 olfactory bulb,
weevaluatedmoreaccuratelypossiblealternativemigratoryfates
of subependymal precursors. Specifically, we hypothesized that,
ifprecursorscellsshowachangeintheirmigrationdestinytothe
olfactorybulbinsymptomaticmice(12weeksofage),thenthese
cellsmightbemigratingtobrainareasaffectedbyHDpathology,
such as the striatum or cortex in an attempt to compensate the
local cell losses. Accordingly, R6/2 and WT mice at 10 weeks of
age were injected with BrdU and killed 30 d later. Analyses of the
striatum adjacent to the lateral ventricle (up to 100 m from the
subependyma)revealedmoreBrdU-positivecellsinthestriatum
in R6/2 mice relative to WT (t(7)  4.44, p  0.05; 66.41 
39.81 BrdU-labeled cells/mm
3 for the WT mice and 871.9  157
fortheR6/2mice).Furthermore,10%oftheBrdU-labeledcells
also expressed PSA-NCAM (Fig. 7A–C), suggesting that they are
migratingneuroblasts,perhapsredirectedawayfromthenormal
migratory pathway to the olfactory bulb in an attempt to com-
pensate for the cell loss in the striatum. In contrast, we did not
observe a significant difference in BrdU-labeled cells in the cere-
bral cortex of R6/2 relative to WT at the same age (Mann–Whit-
ney U test, Z  0.894; p  0.371).
Toanalyzethepotentialdifferentphenotypesofthelong-term
survival, BrdU-positive cells in the striatum, we performed im-
munostainingandquantifiedcellsdoublelabeledforNeuN,nes-
tin, or GFAP. The relative percentages of BrdU double-labeled
cells in the WT versus R6/2 postmitotic striatal tissue were not
significantlydifferent(t(4)1.015;p0.05).Nevertheless,there
was a tendency for a decrease in the percentage of BrdU
 cells
that were also GFAP
 in the R6/2 compared with WT striatum,
i.e., the absolute number of new astrocytes are decreased in R6/2
(Fig. 8). Conversely, the percentage of BrdU
 striatal cells that
were double labeled for NeuN showed a nonsignificant increase
(t5  1.188; p  0.05) in the R6/2 compared with WT striatum
withatendencyofmorenewneuronsinR6/2(Fig.8).Mostofthe
increased R6/2 cell types within the subependyma are nestin

and GFAP
 double-labeled cells (Fig. 2), which suggests that
these cells are neural stem cells. However, some of these sub-
ependymal cells may also be postmitotic reactive astrocytes. We
found no significant increases in the relative percentages of
BrdU
 cells that are neurons or glia within the R6/2 compared
with WT striatum itself. Nevertheless, because there are more
BrdU
 cells in the R6/2 than WT postmitotic striatum (BrdU

cells after 30 d of survival), then there certainly are absolutely
more neurons and glial cells in the R6/2 striatum, including ap-
proximately five times more astrocytes in R6/2 compared with
WT. Thus, more stem cells may have produced absolutely more
striatal astrocytes after 30 d of survival. Moreover, some of the
astrocyte progenitors already in the striatum also may have ac-
counted for some of the five times increase in the number of
astrocytes in R6/2 compared with wild-type striatum.
Although we observed a 10-fold increase in the number of
30-d-survival BrdU
 cells in the R6/2 compared with WT stria-
tum (BrdU
 cells in the lateral ventricle after 30 d of survival),
only approximately one-half of the BrdU-positive cells 30 d after
BrdU injection, in both R6/2 and WT mice, were double labeled
withNeuN,nestin,orGFAP.Onepossibilitytoexplainthisresult
is that some of these BrdU
 cells in the striatum might be endo-
thelial cells or blood-derived cells. Another possibility is that
someofthenewcellsintheR6/2andWTstriatummightbeother
cell types generated from NSCs (oligodendrocytes or nestin
/
NeuN
 young neuron) that were not sampled here.
Discussion
The present study demonstrates that forebrain neural precursor
cellsareactivatedinamurinetransgenicmodelofHD.Theonset
of motor symptoms in the R6/2 mouse is accompanied by a pro-
gressiveincreaseinnumbersofforebrainstemcellsinthestriatal
subependyma. This increase in forebrain neural stem cells was
demonstrated in three separate assays: a increased number of
clonal neurospheres in vitro from the R6/2 mice, an increased
numberofBrdU
labelretainingcells(30dafterBrdUinjection)
intheR6/2subependymainvivo(cellsthatexpressedbothnestin
andGFAP,furthersuggestingtheirstemcellidentity),andfinally
Figure6. R6/2progenitorcellshaveadeficitinmigrationtotheolfactorybulb.A,B,Rep-
resentativesectionsofBrdU-labeledcellsintheGCLoftheolfactorybulbinbothR6/2andWT
miceat13weeksofage(7dsurvival).Animalswerekilled7dafterBrdUinjections.Alldataare
expressedasmeanSEM.Scalebar,100m.*p0.05.RMS,Rostralmigratorystream.
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R6/2 subependyma at the EM level. More-
over, R6/2 stem cells from symptomatic,
but not presymptomatic, mice exhibit po-
tentiatedself-renewalduringserialpassag-
ing in vitro (i.e., the effect occurs only in
vivo but persists in vitro), suggesting that
thepotentiatedself-renewalofstemcellsis
induced by cell non-autonomous factors
in the neurodegenerative brain but is
maintained cell autonomously once it is
induced.Furthermore,theeffectisspecific
to stem cells because the numbers of pro-
genitors cells are not influenced either in
vitro or in vivo. The adult subependyma
consists of at least two kinetically distinct
cell populations: a relatively quiescent
stemcellpopulationandaconstitutivelyproliferatingprogenitor
cell population (Morshead et al., 1994). The postmitotic fate of
the constitutively proliferating cell population has been deter-
mined to be cell death or neuronal differentiation and migration
totheolfactorybulb(MorsheadandvanderKooy,1992;Loisand
Alvarez-Buylla,1994).Thepresentresultsdemonstrateagradual
increaseinthenumbersofstriatalneuralstemcellsthatcorrelates
with symptomatic disease progression. Furthermore, this in-
creased expansion was maintained (once induced) but was not
induced during in vitro passaging of clonal neurosphere cultures
from presymptomatic R6/2 mice. These findings imply that
the progression of the disease in the host brain cell non-
autonomously induces symmetrical divisions in the neural stem
cellpopulationinvivo.Incontrast,theprogenitorcellpopulation
did not appear to be altered during the onset of R6/2 symptoms.
No differences were detected in the total numbers of neural pro-
genitorcellsbetweensymptomaticR6/2andtheirWTcontrolsin
vivo as measured by either BrdU and PCNA immunostaining
(nor in their neuronal or glial phenotypes), which is consistent
with the findings of other recent reports (Gil et al., 2004; Phillips
et al., 2005). Furthermore, despite increased neural stem cell
symmetric divisions, neurosphere cultures from R6/2 forebrain
do not incorporate BrdU faster than neurospheres cultured cells
from WT in vitro. Given that neural stem cell proliferation pre-
dominantly gives rise to progenitor cells via asymmetric cell di-
visions in vivo, it is surprising that the increased numbers of
forebrain stem cells in the R6/2 brain does not produce an indi-
rect increase in the numbers of their neural progenitor progeny.
Hence, the symptomatic R6/2 brain may produce an environ-
mentinwhicheitherstemcellsmaybeinhibitedintheirabilityto
make asymmetric divisions (perhaps attributable to reprogram-
ming toward symmetric divisions) or there may be altered sur-
vival and migratory kinetics of progenitor cells out of the sub-
ependyma counteracting increases in stem cell proliferation, or a
combination of these factors.
ThepotentialgrowthfactorsintheHDstriatumthatmightbe
associatedwiththeincreasedneuralstemcellself-renewalremain
unknown. However, endothelial cells have fundamental roles in
neurogenic niches. Progenitor cells are found in close proximity
to the tips of capillaries, and NSCs in the subependyma lie adja-
centtotheependymallayerthatlinesthelateralventriclesandthe
bloodvessels(Palmeretal.,2000;Ramı ´rez-Castillejoetal.,2006).
Furthermore, vasculature-secreted factors promote precursor
cell proliferation and/or survival (Jin et al., 2002). Blood-borne
inflammatory signals also are counteracted by endogenous anti-
inflammatory factors such as pigment epithelium-derived factor
(PEDF) (Zhang et al., 2006). PEDF is elevated in CSF of patients
with amyotrophic lateral sclerosis (Kuncl et al., 2002) and in
patients with Alzheimer’s disease (Castano et al., 2006). PEDF
recently was suggested as a niche signal for neural stem cell re-
newal (Ramı ´rez-Castillejo et al., 2006). PEDF is the first soluble
factor known to activate B cells specifically, and factors such as
PEDFareviablecandidatemediatorsoftheeffectsonneuralstem
cells in the HD brain. Conversely, dopamine specifically inhibits
neural stem cell proliferation (Kippin et al., 2005b), and striatal
dopamine levels are decreased in symptomatic R6/2 (Hickey et
al., 2002) and R6/1 (Petersen et al., 2002; Pineda et al., 2005),
suggesting that loss of tonic dopaminergic inhibition of stem cell
proliferation also could mediate some of the effects seen in the
R6/2 subependyma.
Remarkably, light microscopic, cytoarchitectural analyses of
human HD subependyma revealed increased numbers of type B
cells (putative stem cells), with no significant increase in the
numbersoftypeAandCcells(putativeprogenitorscells)(Curtis
et al., 2005b). Similar increases in type B cells were seen in the
R6/2 subependyma in the present report. Furthermore, the in-
creasesinstemcellsinHDpatientscorrelatedwithadvancement
of HD symptoms (Curtis et al., 2005a). Thus, in both the human
andthemousebrain,expandedCAGrepeatpathologyappearsto
induceaspecificincreaseinforebrainstemcells.Ourpresentdata
demonstrate that these increases in stem cells are mediated
through the ability of the microenvironment of the HD brain to
Figure 7. R6/2 progenitor cells are redirected into the striatum. A–C, Representative section showing one double-labeled
(arrow)PSA-NCAM(A)andBrdU(B)cellinthestriatumofanR6/2mouseat13weeksofage(7dsurvival).C,Mergedimages.LV,
Lateralventricle;Str,striatum;SE,subependyma.Scalebar,10m.
Figure8. PhenotypesofBrdU-positivecellsinthestriatumofWTandR6/2mice.Specific
markerswereusedtocharacterizeBrdU
cells30dafterBrdUinjection.Thereisanonsignifi-
cant(t(5)1.188;p0.05)tendencyfortheR6/2striatumtohaveagreaterpercentageof
BrdU
neurons(NeuN
cells).ThepercentageofBrdU
cellsdoublelabeledforGFAPinthe
R6/2micedoesnotshowarelativeastrocytosisinthestriatumcomparedwithWTmice,but,
given the greater number of BrdU
 cells, there are absolutely more astrocytes in the R6/2
striatum.
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ric divisions.
Thesecondmaineffectonneuralprecursorsseeninthesymp-
tomatic R6/2 brain is the decreased number of neuroblasts mi-
grating to their normal targets in the olfactory bulb and the in-
creasednumberofneuralprecursorsmigratingintothestriatum.
Examination of BrdU-labeled cells in the striatum after short-
term survival in 12 week R6/2 mice revealed no increase in the
number of BrdU-labeled cells, whereas significantly more BrdU-
labeled cells were seen in the striatum at 30 d. Although the rela-
tive proportions of neurons to astroglial cells were similar in WT
and R6/2 striatum, the absolute increases in new cells in the R6/2
striatum 30 d after BrdU means that absolutely more new neu-
rons and new glial cells were populating the R6/2 striatum. Neu-
ronal loss has not been reported in the R6/2 striatum. It is rea-
sonable to suggest that the absolute increase in new neurons that
weseeintheR6/2striatummayhideasmalllossofoldneuronsin
thisstructure.Othernew(30dafterBrdU
)R6/2striatalcellsare
apparently non-neuronal and non-astroglial. This suggests that
theHDpathologymightencouragetheproliferationofothercell
types such as endothelial cells or oligodendrocytes in the HD
striatum. However, microglia density is decreased by 7 weeks of
age in R6/2 mice (Ma et al., 2003), suggesting that the BrdU-
labeled cells migrating into the striatum are unlikely to include
many microglial cells.
Neuroblast migration along the rostral migratory stream is
preciselyregulatedbycooperationbetweenseveralrepellants,at-
tractants,guidance,andtrophicmoleculeslocatedwithinspecific
brain regions. Infusion of BDNF into or viral-induced BDNF
overexpression in the lateral ventricles of adult rats can substan-
tially increase the number of newly generated neurons in the
olfactory bulb and the striatum (Zigova et al., 1998; Benraiss et
al., 2001; Chmielnicki et al., 2004). The reduced migration to the
olfactory bulb may reflect reduced levels of BDNF reported in
R6/2 mouse brains (Saudou et al., 1998; Zuccato et al., 2005).
The present report quantitates the longer-term (30 d after
BrdU injection) fates of the new cells in the R6/2 and wild-type
striatum.WeshowthattherearemoreabsoluteBrdU
cellsthat
survive in the R6/2 compared with wild-type striatum. However,
the relative proportions of new neurons and new glial do not
change significantly between the R6/2 versus wild-type striatum.
Nevertheless, there are absolutely more new neurons and new
astrocytes in the R6/2 striatum, because there are so many new
BrdU-labeledcellsintheR6/2comparedwithwild-typestriatum.
Certainly,theincreaseinastrocytesmayreflectthedamagedR6/2
striatum. This may result in more astrocytes migrating into the
R6/2 striatum. The increased absolute numbers of new neurons
in the R6/2 could also reflect a response to damage in the R6/2
striatumbut,inaddition,couldbeaconsequenceoftheapparent
buildup of migrating neurons in the proximal rostral migratory
stream of the R6/2 mice. If these new rostral migratory stream
neurons are not migrating correctly to the olfactory bulb, they
may be diverted to the striatum (Decker et al., 2002). Buildup of
neurons in the rostral migratory stream may not be a sufficient
reasonforneuronstomigrateintothestriatum,asdemonstrated
in NCAM mutant mice (Tomasiewicz et al., 1993). However, in
combination with a signal produced in the dysfunctional R6/2
striatum, the buildup of new neurons in the R6/2 rostral migra-
tory stream may produce spillover of the new neurons into the
R6/2 striatum.
Inconclusion,ourfindingsshow,invitroandinvivo,thatHD
adultforebrainexhibitsincreasednumbersofstriatalsubependy-
mal neural stem cells as a result of cell non-autonomous events,
perhaps triggered by changes in the neurochemical environment
oftheHDstriatum.Simultaneously,changesinchemoattractant
orchemorepulsivemoleculesintheHDstriatummayencourage
the migration of striatal subependymal progenitor cells toward
the degenerated striatum in HD. The present data support the
notionthatadultsubependymalprecursorscangenerateprogeny
that migrate toward injured areas and thus potentially be har-
nessed for neural repair.
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